Monday - November 3, 2025
Kirkland Advises Sihuan Pharm and Xuanzhu Biopharm on Successful Spin-off and Separate Listing of Xuanzhu Biopharm
October 16, 2025
CHICAGO, Illinois, Oct. 16 [Category: BizLaw/Legal] -- Kirkland and Ellis, a law firm, issued the following news release:

* * *

Kirkland Advises Sihuan Pharm and Xuanzhu Biopharm on Successful Spin-off and Separate Listing of Xuanzhu Biopharm

*

Kirkland & Ellis represented Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharm, HKSE: 460) and Xuanzhu Biopharmaceutical Co., Ltd. (Xuanzhu Biopharm, HKSE: 2575) on the spin-off, the global off . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products